CUE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Cue Biopharma Inc (CUE) is not a strong buy at this time for a beginner investor with a long-term strategy. The stock shows weak financial performance, no significant positive catalysts, and bearish technical indicators. While the options data suggests minimal bearish sentiment, the lack of recent news, analyst ratings, and congress trading activity further limits the attractiveness of this stock for long-term investment.
The stock's technical indicators are bearish. The MACD is slightly positive but contracting, RSI is neutral at 31.967, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels (Pivot: 0.328, S1: 0.297), indicating weak momentum.
NULL identified. No recent news, analyst upgrades, or significant trading trends from hedge funds or insiders.
is also down 1.54%, reflecting a bearish sentiment.
In Q3 2025, revenue dropped to $2,149,000 (-35.58% YoY), net income dropped to -$7,448,000 (-14.00% YoY), and EPS dropped to -0.07 (-58.82% YoY). Gross margin remained stable at 100%. Overall, the company is struggling with declining financial metrics.
No recent analyst ratings or price target changes are available for Cue Biopharma Inc.
